Curt Mazur

5.5k total citations · 2 hit papers
45 papers, 3.4k citations indexed

About

Curt Mazur is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Curt Mazur has authored 45 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 13 papers in Immunology and 7 papers in Genetics. Recurrent topics in Curt Mazur's work include Mast cells and histamine (9 papers), Receptor Mechanisms and Signaling (9 papers) and RNA Research and Splicing (7 papers). Curt Mazur is often cited by papers focused on Mast cells and histamine (9 papers), Receptor Mechanisms and Signaling (9 papers) and RNA Research and Splicing (7 papers). Curt Mazur collaborates with scholars based in United States, Australia and Greece. Curt Mazur's co-authors include Timothy W. Lovenberg, Holly Kordasiewicz, Edward V. Wancewicz, C. Frank Bennett, Don W. Cleveland, Fredrik Kamme, Yalda Sedaghat, Stephanie C. Huelga, Magdalini Polymenidou and Kasey R. Hutt and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Curt Mazur

40 papers receiving 3.3k citations

Hit Papers

Long pre-mRNA depletion and RNA missplicing contribute to... 2011 2026 2016 2021 2011 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Curt Mazur United States 22 2.0k 899 819 603 427 45 3.4k
Willeke van Roon‐Mom Netherlands 39 2.8k 1.4× 778 0.9× 2.1k 2.5× 458 0.8× 438 1.0× 109 4.6k
Cinzia Volonté Italy 42 1.6k 0.8× 836 0.9× 1.2k 1.4× 407 0.7× 439 1.0× 130 5.0k
Margaret A. Pericak‐Vance United States 34 2.2k 1.1× 650 0.7× 1.6k 2.0× 483 0.8× 1.1k 2.6× 71 5.2k
Hidemi Misawa Japan 41 3.3k 1.7× 1.6k 1.7× 1.6k 1.9× 925 1.5× 634 1.5× 114 5.7k
Eiichiro Nagata Japan 30 2.1k 1.1× 485 0.5× 1.2k 1.5× 133 0.2× 588 1.4× 117 4.0k
Laurent Roybon Sweden 30 1.8k 0.9× 1.1k 1.2× 1.2k 1.4× 506 0.8× 638 1.5× 64 3.6k
Alfredo Gorio Italy 35 2.1k 1.1× 447 0.5× 2.4k 3.0× 444 0.7× 766 1.8× 151 5.1k
Sergio Schinelli Italy 28 1.6k 0.8× 307 0.3× 1.3k 1.6× 200 0.3× 318 0.7× 58 4.1k
Philippe Ravassard France 36 2.8k 1.4× 173 0.2× 1.6k 1.9× 313 0.5× 387 0.9× 100 5.9k
Natalia Ninkina United Kingdom 38 1.8k 0.9× 2.1k 2.3× 1.4k 1.8× 250 0.4× 988 2.3× 103 4.3k

Countries citing papers authored by Curt Mazur

Since Specialization
Citations

This map shows the geographic impact of Curt Mazur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curt Mazur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curt Mazur more than expected).

Fields of papers citing papers by Curt Mazur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curt Mazur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curt Mazur. The network helps show where Curt Mazur may publish in the future.

Co-authorship network of co-authors of Curt Mazur

This figure shows the co-authorship network connecting the top 25 collaborators of Curt Mazur. A scholar is included among the top collaborators of Curt Mazur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curt Mazur. Curt Mazur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mazur, Curt, Oleksandr Platoshyn, Sebastien A. Burel, et al.. (2025). Acute neuronal inhibition response caused by phosphorothioate antisense oligonucleotides following local delivery to the central nervous system. Nucleic Acids Research. 54(3).
2.
Lackinger, Martin, Anastasia Diamantopoulou, Yijing Chen, et al.. (2025). An antisense oligonucleotide-based strategy to ameliorate cognitive dysfunction in the 22q11.2 Deletion Syndrome. eLife. 13.
3.
Viengkhou, Barney, Christine Hong, Curt Mazur, et al.. (2024). Interferon-α receptor antisense oligonucleotides reduce neuroinflammation and neuropathology in a mouse model of cerebral interferonopathy. Journal of Clinical Investigation. 134(4). 11 indexed citations
5.
Zhao, Hien, Andrew G. Reidenbach, Eric Kuhn, et al.. (2022). Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS. JCI Insight. 7(6). 10 indexed citations
6.
Hagemann, Tracy L., Berit Powers, Ahmed F. Mohamed, et al.. (2021). Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment. Science Translational Medicine. 13(620). eabg4711–eabg4711. 31 indexed citations
7.
Jafar‐Nejad, Paymaan, Berit Powers, Armand Soriano, et al.. (2020). The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration. Nucleic Acids Research. 49(2). 657–673. 62 indexed citations
8.
Damle, Sagar, Edward V. Wancewicz, Swagatam Mukhopadhyay, et al.. (2019). A modular analysis of microglia gene expression, insights into the aged phenotype. BMC Genomics. 20(1). 164–164. 23 indexed citations
9.
Marsala, Silvia, Michael Navarro, Manabu Kakinohana, et al.. (2018). Time-dependent, bidirectional, anti- and pro-spinal hyper-reflexia and muscle spasticity effect after chronic spinal glycine transporter 2 (GlyT2) oligonucleotide-induced downregulation. Experimental Neurology. 305. 66–75. 2 indexed citations
10.
Mohan, Apoorva, Bethany Fitzsimmons, Hien Zhao, et al.. (2017). Antisense oligonucleotides selectively suppress target RNA in nociceptive neurons of the pain system and can ameliorate mechanical pain. Pain. 159(1). 139–149. 22 indexed citations
11.
Swayze, Eric E., Berit Powers, Fredrik Kamme, et al.. (2016). Kinetics of ASO Distribution and Pharmacodynamics in the CNS after an Intrathecal Bolus Dose in Rat (S38.008). Neurology. 86(16_supplement). 1 indexed citations
12.
Wolf, Daniel, Jenna Sullivan‐Stack, Curt Mazur, et al.. (2016). The Effect of Bolus Volume and Mechanical Forces on the Biodistribution of ASOs Following Lumbar Intrathecal Administration in Cynomolgus Monkeys (S38.007). Neurology. 86(16_supplement). 3 indexed citations
13.
Kordasiewicz, Holly, Lisa M. Stanek, Edward V. Wancewicz, et al.. (2012). Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis. Neuron. 74(6). 1031–1044. 563 indexed citations breakdown →
14.
Sedaghat, Yalda, Curt Mazur, Mahyar Sabripour, Gene Hung, & Brett P. Monia. (2012). Genomic Analysis of wig-1 Pathways. PLoS ONE. 7(2). e29429–e29429. 6 indexed citations
15.
Jablonowski, Jill A., Kiev S. Ly, Curt A. Dvorak, et al.. (2008). Novel imidazole-based histamine H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(3). 903–907. 7 indexed citations
16.
Keith, John M., Ann Barbier, Sandy J. Wilson, et al.. (2007). Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(15). 4374–4377. 25 indexed citations
17.
Keith, John M., Ronald Wolin, Ann Barbier, et al.. (2007). Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(9). 2603–2607. 23 indexed citations
18.
Keith, John M., Michael A. Letavic, Kiev S. Ly, et al.. (2006). Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophore. Bioorganic & Medicinal Chemistry Letters. 17(3). 702–706.
19.
Chai, Wenying, J. Guy Breitenbucher, Annette K. Kwok, et al.. (2003). Non-imidazole heterocyclic histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(10). 1767–1770. 101 indexed citations
20.
Tschopp, J, et al.. (1994). [26] Therapeutic application of matrix biology. Methods in enzymology on CD-ROM/Methods in enzymology. 245. 556–569. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026